Literature DB >> 2062802

Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.

D S Chien1, H Sasaki, H Bundgaard, A Buur, V H Lee.   

Abstract

The main objective of this study was to investigate how enzymatic lability would affect the extent of corneal and conjunctival penetration of a series of alkyl, cycloalkyl, and aryl ester prodrugs of timolol in the pigmented rabbit. Enzymatic lability of the prodrugs was studied in corneal epithelial and conjunctival homogenates, while their corneal and conjunctival penetration was determined using the isolated tissues in the modified Ussing chamber. The straight-chain alkyl and the unsubstituted cycloalkyl esters were hydrolyzed more rapidly than their corresponding branched-chain and substituted analogues as well as the aryl esters. The corneal and conjunctival penetration of all prodrugs, regardless of enzymatic lability, varied parabolically with lipophilicity. Moreover, the enzymatically more labile straight-chain alkyl esters penetrated the cornea and the conjunctiva more readily than the more stable branched-chain esters of comparable lipophilicity. Enzymatic lability is, therefore, an additional factor that should be considered in designing alkyl ester prodrugs with improved ocular drug delivery characteristics. Enzymatic lability does not, however, play as important a role as lipophilicity in the corneal and conjunctival penetration of cycloalkyl and aryl ester prodrugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062802     DOI: 10.1023/a:1015845916293

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  IN VITRO ION AND WATER MOVEMENT IN CORNEAS OF RAINBOW TROUT.

Authors:  H F EDELHAUSER; J R HOFFERT; P O FROMM
Journal:  Invest Ophthalmol       Date:  1965-06

2.  Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.

Authors:  V H Lee; D S Chien; H Sasaki
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

3.  Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.

Authors:  S C Chang; V H Lee
Journal:  J Ocul Pharmacol       Date:  1987

4.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

5.  Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.

Authors:  S C Chang; D S Chien; H Bundgaard; V H Lee
Journal:  Exp Eye Res       Date:  1988-01       Impact factor: 3.467

6.  Penetration routes of topically applied eye medications.

Authors:  M G Doane; A D Jensen; C H Dohlman
Journal:  Am J Ophthalmol       Date:  1978-03       Impact factor: 5.258

7.  Low dose O-butyryl timolol improves the therapeutic index of timolol in the pigmented rabbit.

Authors:  S C Chang; H Bundgaard; A Buur; V H Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-04       Impact factor: 4.799

8.  Timolol prodrugs: preparation and hydrolysis kinetics of N-benzoyl carbamate esters of timolol and related compounds.

Authors:  H Bundgaard; A Buur; V H Lee
Journal:  Acta Pharm Suec       Date:  1988

9.  Influence of corneal epithelial integrity on the penetration of timolol prodrugs.

Authors:  D S Chien; H Bundgaard; V H Lee
Journal:  J Ocul Pharmacol       Date:  1988

10.  Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1984-08       Impact factor: 3.534

View more
  7 in total

1.  Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.

Authors:  Y B Chung; K Han; A Nishiura; V H Lee
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 2.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

3.  Light-responsive biomaterials for ocular drug delivery.

Authors:  Hend A M Abdelmohsen; Nikki A Copeland; John G Hardy
Journal:  Drug Deliv Transl Res       Date:  2022-06-24       Impact factor: 4.617

4.  Effluxing ABC transporters in human corneal epithelium.

Authors:  Kati-Sisko Vellonen; Eliisa Mannermaa; Helen Turner; Marika Häkli; J Mario Wolosin; Timo Tervo; Paavo Honkakoski; Arto Urtti
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

5.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

6.  Conjunctival penetration of insulin and peptide drugs in the albino rabbit.

Authors:  E Hayakawa; D S Chien; K Inagaki; A Yamamoto; W Wang; V H Lee
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

7.  Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam; Rama Sarma Gadepalli; John M Rimoldi; Michael A Repka
Journal:  Pharm Res       Date:  2008-10-07       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.